UK market research provider Fairfield shared its latest study on the global psychedelic drugs market . According to the company, it reached $3.210 million in 2021 and $6.330 million by 2026.
More specifically, the report predicts that the market will surge at a Compound Annual Growth Rate (CAGR ) of 14.5% between 2021 and 2026.
The rise in numbers will most likely be due to the growing vocabulary of the younger generation around mental health, erasing taboos and re-evaluating the call for help, says Fairfield.
The research includes a global psychedelic drugs market outlook and incremental opportunity for the period 2018-2026; outlooks and attractiveness by product value, disease indication, route of administration, origin ...
Full story available on Benzinga.com